SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950123-10-011417
Filing Date
2010-02-11
Accepted
2010-02-11 13:30:10
Documents
1
Group Members
BIOTECH TARGET N.V.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A w77253esc13gza.txt SC 13G/A 8129
  Complete submission text file 0000950123-10-011417.txt   10136
Mailing Address VODERGASSE 3 SWITZERLAND SCHAFFHAUSEN V8 CH-8300
Business Address VODERGASSE 3 SWITZERLAND SCHAFFHAUSEN V8 CH-8300 411724 59 59
BB BIOTECH AG (Filed by) CIK: 0000924223 (see all company filings)

State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 0000

Mailing Address 1201 EASTLAKE AVENUE E SEATTLE WA 98102
Business Address 1201 EASTLAKE AVENUE E SEATTLE WA 98102 206-442-6600
ZYMOGENETICS INC (Subject) CIK: 0001129425 (see all company filings)

IRS No.: 911144498 | State of Incorp.: WA | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-78019 | Film No.: 10590741
SIC: 2836 Biological Products, (No Diagnostic Substances)